OTTAWA, May 7 (Reuters) - Canada on Friday said that it was
ready to discuss an intellectual property rights (IP) waiver for
COVID-19 vaccines while it also recognized the importance of
protecting IP and the integral role industry played in
developing the medicines.
"Canada is ready to discuss proposals on a waiver for
intellectual property (IP) protection, particular to COVID-19
vaccines, under the WTO Agreement on TRIPS," International Trade
Minister Mary Ng said in a statement.
"Our government firmly believes in the importance of
protecting IP and recognizes the integral role that industry has
played in innovating to develop and deliver life-saving COVID-19
vaccines."
(Reporting by Steve Scherer
Editing by David Goodman
)
Astrazeneca (AZN)
